Accordingly, drugs affecting acetylcholine (ACh) levels, basically acetylcholinesterase inhibitors (AChE-Is) were considered for the use as therapeutic agents for AD (Dall'acqua, 2013). This evidence concerns the gene ACHE and Alzheimer disease.